FDA DEVICE FACTS
BreathID Hp System
Exalenz Bioscience , Ltd.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The Exalenz BreathID ® Hp System is intended for use to continually and non-invasively measure changes in the 13 CO 2 /12 CO 2 ratio of exhaled breath, which may be indicative of increased urease production associated with active Helicobacter pylori (H. pylori ) infection in the stomach.
The Exalenz BreathID ® Hp System is indicated for use as an aid in the initial diagnosis and post treatment monitoring of H. pylori infection in adult patients and pediatric patients ages 3-17 years old. The Exalenz BreathID ® Hp System consists of the appropriate IDkit:Hp™ kit and the BreathID ® Hp test device.
The device is for use by trained health care professionals. To be administered under a physician's supervision.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。